Logo

Welcome to I See Blood Cancer

I See Blood Cancer is a dedicated online resource for healthcare professionals to learn about the diagnosis and management of rare haematological malignancies: AL amyloidosis, Waldenström's macroglobulinemia, mantle cell lymphoma, and acute myeloid leukaemia.

To find comprehensive information on areas of specific interest click on the buttons below:

I see AL amyloidosis

The latest insights into diagnosing and treating AL amyloidosis.

I see Waldenström’s macroglobulinemia (WM)

Up to date information around identifying, diagnosing and treating WM.

I see mantle cell lymphoma (MCL)

Current advice regarding the diagnosis and treatment of MCL.

I see acute myeloid leukaemia (AML)

Most recent guidance into diagnosing and treating acute myeloid leukaemia.

CP-284250

The I See Blood Cancer campaign is an initiative to raise awareness on less common hematological malignancies. Research has shown that identifying less common diseases can be a challenge for non-experts, which can lead to delayed diagnosis and treatment in patients.[1][2]

I See Blood Cancer aims to bring knowledge and resources to the forefront so that HCPs are well equipped to identify, treat, manage and support patients with these rare blood cancers.

Janssen Haematology

Information about blood cancers and resources to help support clinical practice.

If you are a patient

Resources and information to help you better understand your disease.

This site has been developed by Janssen-Cilag International NV. Janssen-Cilag International NV is the responsible editor of this document.

References

Lopes MT, et al. Difficulties in the diagnosis and treatment of rare diseases according to the perceptions of patients, relatives and health care professionals. Clinics (Sao Paulo). 2018;73:e68.
Ramalle-Gómara E, et al. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;17:15(1):18.
ITEM CODE: CP-248784 | DATE OF PREPARATION: July 2021